158 related articles for article (PubMed ID: 17234298)
21. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
[TBL] [Abstract][Full Text] [Related]
22. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
[TBL] [Abstract][Full Text] [Related]
24. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
25. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.
Kang ES; Kim HJ; Ahn CW; Park CW; Cha BS; Lim SK; Kim KR; Lee HC
Diabetes Res Clin Pract; 2005 Aug; 69(2):151-9. PubMed ID: 16005364
[TBL] [Abstract][Full Text] [Related]
26. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study.
Mannucci E; Monami M; Rotella CM
Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):719-26. PubMed ID: 17387006
[TBL] [Abstract][Full Text] [Related]
27. Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men.
Levisianou D; Melidonis A; Adamopoulou E; Skopelitis E; Koutsovasilis A; Protopsaltis I; Zairis M; Kougialis S; Skoularigis I; Koukoulis G; Foussas S; Triposkiadis F
Int Angiol; 2009 Dec; 28(6):490-5. PubMed ID: 20087288
[TBL] [Abstract][Full Text] [Related]
28. Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects.
Ukkola O; Kesäniemi YA
Metabolism; 2007 Sep; 56(9):1221-7. PubMed ID: 17697865
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
30. Probable blind spot in the International Diabetes Federation definition of metabolic syndrome.
Chen HJ; Pan WH
Obesity (Silver Spring); 2007 May; 15(5):1096-100. PubMed ID: 17495185
[TBL] [Abstract][Full Text] [Related]
31. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
Monami M; Marchionni N; Masotti G; Mannucci E
Diabetes Obes Metab; 2007 May; 9(3):350-3. PubMed ID: 17391162
[TBL] [Abstract][Full Text] [Related]
32. Association of non-HDL cholesterol with subclinical atherosclerosis in HIV-positive patients.
Badiou S; Thiebaut R; Aurillac-Lavignolle V; Dabis F; Laporte F; Cristol JP; Mercie P;
J Infect; 2008 Jul; 57(1):47-54. PubMed ID: 18554723
[TBL] [Abstract][Full Text] [Related]
33. Relationship between metabolic syndrome and its components with coronary heart disease in Iranian men and women.
Zabetian A; Hadaegh F; Azizi F
Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):525-31. PubMed ID: 18523915
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population.
Császár A; Kékes E; Abel T; Papp R; Kiss I; Balogh S
Blood Press; 2006; 15(2):101-6. PubMed ID: 16754273
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions.
Bhattacharya SM
Gynecol Endocrinol; 2010 Jul; 26(7):516-20. PubMed ID: 20540665
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and correlates of metabolic syndrome (MS) in older adults.
Cankurtaran M; Halil M; Yavuz BB; Dagli N; Oyan B; Ariogul S
Arch Gerontol Geriatr; 2006; 42(1):35-45. PubMed ID: 16046242
[TBL] [Abstract][Full Text] [Related]
37. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
38. Microalbuminuria and the metabolic syndrome and its components in the Chinese population.
Lin CC; Liu CS; Li TC; Chen CC; Li CI; Lin WY
Eur J Clin Invest; 2007 Oct; 37(10):783-90. PubMed ID: 17888089
[TBL] [Abstract][Full Text] [Related]
39. Predictors of metabolic syndrome in Asian north Indians with newly detected type 2 diabetes.
Dhanaraj E; Bhansali A; Jaggi S; Dutta P; Jain S; Tiwari P; Ramarao P
Indian J Med Res; 2009 May; 129(5):506-14. PubMed ID: 19675377
[TBL] [Abstract][Full Text] [Related]
40. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
